1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62506C0C42086970100258D26004BA45E
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/2506C0C42086970100258D26004BA45E?OpenDocument
18
19OpenDocument
2018.97.14.90
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Affairs Excellence

Document Excerpt: CNS Medical Affairs Impact Equation: Demonstrating Strategic Impact Through Outcomes and Data

DB Image

ID: MD-998


Features:

13 Info Graphics

13 Data Graphics

230+ Metrics

9 Narratives


Pages/Slides: 4


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt".

To return to the study abstract to purchase the full study -
click here

This excerpt includes research findings and metrics from document #5898 “CNS Medical Affairs Impact Equation: Demonstrating Strategic Impact Through Outcomes and Data”.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Health Care; Medical Device


Companies Profiled:
AbbVie; Alnylam Pharmaceuticals; Amgen; Azurity Pharmaceuticals; Boehringer Ingelheim; Eurofarma; Jazz Pharmaceuticals; Johnson & Johnson; Otsuka; Scholar Rock; Supernus; Takeda

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.